Summit Therapeutics SMMT
NASDAQ SMMT
$17.06 -0.77 (-4.32%)
As of: Nov 11, 2026 · 11:43 AM EST

Summit Therapeutics (SMMT) Shares Outstanding (2014 - 2026)

Updated

Summit Therapeutics' Weighted Average Shares Outstanding came in at 798.2 million for Q3 2026, up 7.4% from 743.42 million a year earlier and up 2.6% from the prior quarter.

Analysis

Summit Therapeutics (SMMT) Shares Outstanding (2014 - 2026) Analysis & Trends

For FY2025, Summit Therapeutics' Weighted Average Shares Outstanding was 747.7 million, up 4.1% from FY2024.

  • Weighted Average Shares Outstanding has increased in each of the last six years, with a five-year compound annual growth rate of 60.8% (FY2020 to FY2025).
  • Going back by year, Weighted Average Shares Outstanding was 718.54 million in FY2024 (+16.0%), 619.65 million in FY2023 (+220.5%), 193.34 million in FY2022 (+109.6%) and 92.24 million in FY2021 (+32.7%).
  • The Q3 2026 figure represents the highest quarterly Weighted Average Shares Outstanding in data going back to Q4 2018.
  • Year-over-year, Weighted Average Shares Outstanding has increased for 24 consecutive quarters, with growth averaging 6.2% over the last eight quarters.
  • The year-over-year growth in Weighted Average Shares Outstanding has ranged between 1.5% (Q2 2024) and 600.1% (Q2 2023) over the last five years.
  • Business Quant data shows SMMT's Weighted Average Shares Outstanding at 778.18 million (Q2 2026), 775.46 million (Q1 2026) and 747.7 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 891.90 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 1.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.47 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 1.94 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 1.55 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 541.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.24 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 5.70 Bn
10 Summit Therapeutics 14.26 Bn 11.63 Bn - 798.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 798.20 Mn
Jun 30, 2026 778.18 Mn
Mar 31, 2026 775.46 Mn
Dec 31, 2025 747.70 Mn
Sep 30, 2025 743.42 Mn
Jun 30, 2025 742.62 Mn
Mar 31, 2025 738.08 Mn
Dec 31, 2024 718.54 Mn
Sep 30, 2024 726.66 Mn
Jun 30, 2024 707.90 Mn
Mar 31, 2024 701.79 Mn
Dec 31, 2023 619.65 Mn
Sep 30, 2023 697.74 Mn
Jun 30, 2023 697.69 Mn
Mar 31, 2023 378.16 Mn
Dec 31, 2022 193.34 Mn
Sep 30, 2022 148.58 Mn
Jun 30, 2022 99.65 Mn
Mar 31, 2022 98.07 Mn
Dec 31, 2021 92.24 Mn
API Access

Summit Therapeutics Shares Outstanding API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding&ticker=SMMT&period=max&api_key=YOUR_API_KEY